CPT® Code 88269

1. Indications

Chromosome analysis, specifically CPT® 88269, is indicated for several clinical scenarios that may suggest the presence of chromosomal abnormalities. The following conditions warrant this analysis:

• Advanced Maternal Age - Women of advanced maternal age are at a higher risk for chromosomal abnormalities in their offspring.
• Abnormal Prenatal Ultrasound Findings - Any unusual findings during prenatal ultrasounds may prompt further investigation through chromosome analysis.
• Abnormal Maternal Blood Screen Results - Results from maternal blood screenings that indicate potential genetic issues can lead to chromosome analysis.
• Previous Child with a Chromosome Anomaly - A history of having a child with chromosomal abnormalities increases the likelihood of recurrence, necessitating chromosome analysis.
• Known Familial Chromosome Rearrangement - If there is a known genetic rearrangement within the family, chromosome analysis can help assess the risk for the current pregnancy.
• Known Familial Genetic Disorder - Families with a history of genetic disorders may require chromosome analysis to evaluate the risk of these conditions in the fetus.

2. Procedure

The procedure for chromosome analysis using CPT® 88269 involves several critical steps to ensure accurate results. The first step is the performance of an amniocentesis, where amniotic fluid is collected from the uterus using specialized syringes. This fluid contains fetal cells that are essential for the analysis. The collected amniotic fluid is then placed in screw-top tubes containing a tissue culture transport medium to preserve the cells during transport to the laboratory.

• Cell Culture - Once in the laboratory, the amniotic fluid cells are cultured in one or more different culture mediums. This process allows the cells to multiply, providing a sufficient number of cells for analysis.
• Counting Colonies - After culturing, the cells from 6 to 12 colonies are counted. This step is crucial as it ensures that there are enough cells to perform a reliable karyotype analysis.
• Karyotyping - A single karyotype is then performed on the cultured cells. Karyotyping involves evaluating the size, shape, and number of chromosomes present in the cell samples.
• Chromosome Banding - Banding techniques, such as Giemsa banding, are employed to stain the chromosomes. This staining process involves several steps, including acetic acid fixation, air drying, and denaturing the chromosomes using proteolytic enzymes or other methods, followed by Giemsa staining. Alternatively, fluorochrome and Q-banding stains may be used.
• Identification of Chromosomal Abnormalities - The final step involves identifying any extra, missing, or abnormal positions of chromosome pieces. This analysis helps in determining the presence of chromosomal abnormalities.

3. Post-Procedure

After the chromosome analysis is completed, the results are typically reviewed and interpreted by a geneticist or a qualified healthcare professional. Patients may receive counseling regarding the findings, especially if abnormalities are detected. The expected recovery from the amniocentesis procedure itself is generally quick, with most patients able to resume normal activities shortly after. However, it is essential to monitor for any complications, such as bleeding or infection, following the procedure. The results of the chromosome analysis can provide critical information for further management and decision-making regarding the pregnancy.